GNRH1 and breast cancer: On the other hand, Sverrisdottir et al. performed a randomized controlled trial (RCT) of 285 premenopausal breast cancer patients and demonstrated that the group that received a GnRH-a had higher rates of resumption of menses compared to the control [6].